This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

QuitAdvisorMD: A Point-of-care Tool for Brief Smoking Cessation Interventions

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified November 2014 by Silverchair Science & Communications, LLC.
Recruitment status was:  Active, not recruiting
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
Silverchair Science & Communications, LLC Identifier:
First received: February 8, 2010
Last updated: November 18, 2014
Last verified: November 2014
QuitAdvisorMD: A point-of-care tool for brief smoking cessation interventions Under a Phase II SBIR grant supported by NIH/NIDA, we are developing QUITAdvisorMD: a point-of-care, patient-centered resource for counseling patients who smoke or use tobacco products. It is based on the principles of Motivational Interviewing, a non-confrontational and very effective method for intervening and treating these patients; the 5 A's of behavioral interventions; and the Transtheoretical Model of Change. Through a point and click interface, the tool uses a series of interview questions designed to motivate patients to stop smoking by first assessing their stage of change and then offering effective stage-based interventions and interview techniques. The tool also offers stage-tailored patient information, a clinician educational reference, and the ability to communicate support information patients via email and/or text message.

Condition Intervention Phase
Smoking Tobacco Use Disorder Other: QuitAdvisorMD Software Algorithm Behavioral: Standard Smoking Cessation Counseling Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: QuitAdvisorMD: A Point-of-care Tool for Brief Smoking Cessation Interventions

Resource links provided by NLM:

Further study details as provided by Silverchair Science & Communications, LLC:

Primary Outcome Measures:
  • The goal of the evaluation is to assess the ability of QuitAdvisorMD to influence smoking cessation as measured by the primary outcome of the increase in physician initiated smoking cessation counseling. [ Time Frame: 12 Months ]

Secondary Outcome Measures:
  • Secondary outcomes will include, 1) the increase in ability of clinicians to provide appropriate stage-based smoking cessation assistance, and 2) the increase in patient quit attempts. [ Time Frame: 12 Months ]

Estimated Enrollment: 100
Study Start Date: January 2011
Estimated Study Completion Date: April 2015
Estimated Primary Completion Date: April 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Software Assisted Lifestyle Counseling Other: QuitAdvisorMD Software Algorithm
QuitAdvisorMD, a set of brief clinical assessments, counseling scripts and intervention instruments for smoking cessation in primary care settings
Active Comparator: Lifestyle Counseling
Status quo smoking cessation counseling.
Behavioral: Standard Smoking Cessation Counseling
Standard Smoking Cessation Counseling


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • any physician providing care for members of Southern Health through primary care and have access to a point-of-care computing device (Smartphone, desktop PC, etc) during patient visits.

Exclusion Criteria:

  • Lack of appropriate computing device
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01065493

United States, Virginia
University of Virginia Health System
Charlottesville, Virginia, United States, 22908
Sponsors and Collaborators
Silverchair Science & Communications, LLC
National Institute on Drug Abuse (NIDA)
Principal Investigator: George Reynolds, BA Silverchair, Inc
Principal Investigator: Scott Strayer, MD University of Virginia Health System
  More Information

Responsible Party: Silverchair Science & Communications, LLC Identifier: NCT01065493     History of Changes
Other Study ID Numbers: R44DA026682 ( U.S. NIH Grant/Contract )
Study First Received: February 8, 2010
Last Updated: November 18, 2014

Additional relevant MeSH terms:
Tobacco Use Disorder
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders processed this record on September 21, 2017